Motor and Non-motor Complications Following Different Early Therapies in Parkinson's Disease: Longitudinal Analysis of Real-Life Clinical and Therapeutic Data from the French NS-PARK Cohort.

Saved in:
Bibliographic Details
Title: Motor and Non-motor Complications Following Different Early Therapies in Parkinson's Disease: Longitudinal Analysis of Real-Life Clinical and Therapeutic Data from the French NS-PARK Cohort.
Authors: Lanore A; Department of Neurology, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, NS-Park/FCRIN Network, Paris, France. aymeric.lanore@icm-institute.org., Januel E; Department of Neurology, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, NS-Park/FCRIN Network, Paris, France.; Département de Santé Publique, Centre de Pharmacoépidémiologie (Cephepi), Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital Pitié Salpêtrière, CIC-1901, 75013, Paris, France., Bertille N; Département de Santé Publique, Centre de Pharmacoépidémiologie (Cephepi), Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital Pitié Salpêtrière, CIC-1901, 75013, Paris, France., Fabbri M; Clinical Investigation Center CIC1436, Parkinson Expert Center, Department of Clinical, Pharmacology and Neuroscience, NS-Park/FCRIN Network, NeuroToul COEN Center, Toulouse, University Hospital, INSERM and University of Toulouse 3, Toulouse, France., Mariani LL; Department of Neurology, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, NS-Park/FCRIN Network, Paris, France.; Assistance Publique Hôpitaux de Paris, Department of Pharmacology, Hôpital Pitié-Salpêtrière, Paris, France., Mangone G; Department of Neurology, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, NS-Park/FCRIN Network, Paris, France., Sambin S; Department of Neurology, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, NS-Park/FCRIN Network, Paris, France., Menon PJ; Department of Neurology, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, NS-Park/FCRIN Network, Paris, France., Tir M; Department of Neurology, NS-Park/FCRIN network, Amiens University Hospital, Amiens, France., Bereau M; Department of Neurology, Hôpital Jean Minjoz, Besançon, France., Meissner WG; CHU Bordeaux, Service de Neurologie des Maladies Neurodégénératives, IMNc, NS-Park/FCRIN Network, 33000, Bordeaux, France., Thiriez C; Department of Neurology, NS-Park/FCRIN Network, CHU Caen, Caen, France., Marques A; Department of Neurology, CHU Clermont-Ferrand, Clermont-Ferrand, France., Remy P; Centre Expert Parkinson and NS-Park/FCRIN Network, CHU Henri Mondor, AP-HP et Equipe Neuropsychologie Interventionnelle, INSERM-IMRB, Faculté de Santé, Université Paris-Est Créteil et Ecole Normale Supérieure PSL Université, Créteil, France., Dupont G; Department of Neurology, François Mitterrand University Hospital, University de Bourgogne, Dijon, France., Moro E; Division of Neurology, Movement Disorders Unit, CHU de Grenoble, Grenoble Institute of Neurosciences, Grenoble Alpes University, Grenoble, France., Defebvre L; Service de Neurologie et Pathologie du Mouvement, Pôle de Neurosciences et Appareil Locomoteur, CHRU de Lille, Lille, France.; INSERM UMR 1171, LILLE France, Troubles Cognitifs Dégénératifs et Vasculaires, Lille, France., Houeto JL; Department of Neurology, NS-Park/FCRIN Network, Limoges University Hospital, Inserm, U1094, EpiMaCT-Epidemiology of Chronic Diseases in Tropical Zone, Limoges University Hospital, 87042, Limoges, France., Thobois S; Hospices Civils de Lyon, Hopital Neurologique Pierre Wertheimer, Department of Neurology C, NS-Park/FCRIN Network, Univ Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux, Lyon, France.; INSERM, Centre de Recherche en Neurosciences de Lyon, PATH-PARK, Bron, France., Azulay JP; Department of Neurology and Movement Disorders, NS-Park/FCRIN Network; APHM, Hôpital Universitaire Timone, 13005, Marseille, France., Geny C; Centre Expert Maladie de Parkinson, Service de Neurologie, Hôpital Gui de Chauliac, Montpellier, France., Frismand S; Department of Neurology, NS-Park/FCRIN Network, University Hospital of Nancy, Nancy, France., Damier P; CHU de Nantes, CIC1413, Nantes & Université de Nantes, UFR Médecine, Nantes, France., Giordana C; Neurology Department, NS-Park/FCRIN Network, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur, Nice, France., Castelnovo G; Department of Neurology, NS-Park/FCRIN Network; CHU de Nîmes, Nîmes, France., Ansquer S; Department of Neurology, University Hospital of Poitiers; INSERM-CIC1402, Poitiers, France., De Maindreville AD; Department of Neurology, NS-park/FCRIN Network, CHU Reims, Reims, France., Drapier S; Department of Neurology, CIC INSERM 1414, Pontchaillou University Hospital, Rennes, France., Maltête D; Department of Neurology, Rouen University Hospital and University of Rouen, France, INSERM U1239, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, NS-Park/FCRIN Network, Mont-Saint-Aignan, France., Tranchant C; Service de Neurologie, NS-Park/FCRIN Network; Hôpitaux Universitaires de Strasbourg, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), INSERM-U964/CNRS-UMR7104/Université de Strasbourg, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg, France., Rascol O; Clinical Investigation Center CIC1436, Parkinson Expert Center, Department of Clinical, Pharmacology and Neuroscience, NS-Park/FCRIN Network, NeuroToul COEN Center, Toulouse, University Hospital, INSERM and University of Toulouse 3, Toulouse, France., Tubach F; Département de Santé Publique, Centre de Pharmacoépidémiologie (Cephepi), Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital Pitié Salpêtrière, CIC-1901, 75013, Paris, France., De Rycke Y; Département de Santé Publique, Centre de Pharmacoépidémiologie (Cephepi), Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital Pitié Salpêtrière, CIC-1901, 75013, Paris, France., Corvol JC; Department of Neurology, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Sorbonne Université, Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, NS-Park/FCRIN Network, Paris, France.
Corporate Authors: French NS-Park Network
Source: CNS drugs [CNS Drugs] 2025 Sep; Vol. 39 (9), pp. 879-891. Date of Electronic Publication: 2025 May 25.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9431220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1934 (Electronic) Linking ISSN: 11727047 NLM ISO Abbreviation: CNS Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1179-1934
DOI:10.1007/s40263-025-01193-5